Logo image of PTWO

PONO CAPITAL TWO INC-CL A (PTWO) Stock Fundamental Analysis

NASDAQ:PTWO - Nasdaq - US73245B1070 - Common Stock - Currency: USD

11  +0.11 (+1.01%)

Fundamental Rating

1

Overall PTWO gets a fundamental rating of 1 out of 10. We evaluated PTWO against 0 industry peers in the Unkown industry. Both the profitability and financial health of PTWO have multiple concerns. PTWO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PTWO had negative earnings in the past year.
PTWO had a negative operating cash flow in the past year.
PTWO Yearly Net Income VS EBIT VS OCF VS FCFPTWO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K -1M -1.5M -2M

1.2 Ratios

Industry RankSector Rank
ROA -5.49%
ROE -9.72%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTWO Yearly ROA, ROE, ROICPTWO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 -2 -4 -6

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PTWO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PTWO Yearly Profit, Operating, Gross MarginsPTWO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

PTWO has less shares outstanding than it did 1 year ago.
PTWO has a worse debt/assets ratio than last year.
PTWO Yearly Shares OutstandingPTWO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
PTWO Yearly Total Debt VS Total AssetsPTWO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

PTWO has an Altman-Z score of 89.28. This indicates that PTWO is financially healthy and has little risk of bankruptcy at the moment.
PTWO has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 89.28
ROIC/WACCN/A
WACCN/A
PTWO Yearly LT Debt VS Equity VS FCFPTWO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

PTWO has a Current Ratio of 0.32. This is a bad value and indicates that PTWO is not financially healthy enough and could expect problems in meeting its short term obligations.
PTWO has a Quick Ratio of 0.32. This is a bad value and indicates that PTWO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
PTWO Yearly Current Assets VS Current LiabilitesPTWO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PTWO have decreased strongly by -300.03% in the last year.
EPS 1Y (TTM)-300.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-395.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTWO Yearly Revenue VS EstimatesPTWO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
PTWO Yearly EPS VS EstimatesPTWO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PTWO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTWO Price Earnings VS Forward Price EarningsPTWO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTWO Per share dataPTWO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PTWO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PONO CAPITAL TWO INC-CL A

NASDAQ:PTWO (9/17/2024, 8:00:00 PM)

11

+0.11 (+1.01%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change34.88%
Ins Owners0.55%
Ins Owner Change0%
Market Cap1.28B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 116.21
P/tB 116.21
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.49%
ROE -9.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z 89.28
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-395.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-363.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-363.68%
OCF growth 3YN/A
OCF growth 5YN/A